Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo.

Azra BlazevicRachel L EdwardsMei XiaChristopher S EickhoffFahreta HamzabegovicKrystal A MezaHuan NingJanice TennantKarla J MosbyJames C RitchieTigisty GirmayLilin LaiMichele McCulloughAllison BeckColleen F KelleySrilatha EdupugantiSarah KabbaniWendy BuchananMamodikoe K MakheneDelia VoroncaSami CherikhJohannes B GollNadine G RouphaelMark J MulliganDaniel F Hoft

Published in: The Journal of infectious diseases (2023)

NCT01868464 (ClinicalTrials.gov).

Keyphrases

open label
phase iii
phase ii
study protocol
clinical trial
endothelial cells
phase ii study
mycobacterium tuberculosis
induced pluripotent stem cells
randomized controlled trial
pulmonary tuberculosis
pluripotent stem cells
hiv aids
emergency department
radiation therapy
hepatitis c virus